187 related articles for article (PubMed ID: 35585756)
1. CRTH2 Mediates Profibrotic Macrophage Differentiation and Promotes Lung Fibrosis.
Cao Y; Rudrakshala J; Williams R; Rodriguez S; Sorkhdini P; Yang AX; Mundy M; Yang D; Palmisciano A; Walsh T; Delcompare C; Caine T; Tomasi L; Shea BS; Zhou Y
Am J Respir Cell Mol Biol; 2022 Aug; 67(2):201-214. PubMed ID: 35585756
[TBL] [Abstract][Full Text] [Related]
2. Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosis.
Zhou Y; Peng H; Sun H; Peng X; Tang C; Gan Y; Chen X; Mathur A; Hu B; Slade MD; Montgomery RR; Shaw AC; Homer RJ; White ES; Lee CM; Moore MW; Gulati M; Lee CG; Elias JA; Herzog EL
Sci Transl Med; 2014 Jun; 6(240):240ra76. PubMed ID: 24920662
[TBL] [Abstract][Full Text] [Related]
3. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
[No Abstract] [Full Text] [Related]
4. Technical advance: The use of tree shrews as a model of pulmonary fibrosis.
Larson-Casey JL; He C; Che P; Wang M; Cai G; Kim YI; El Hamdaoui M; Grytz R; Ding Q; Carter AB
PLoS One; 2020; 15(11):e0241323. PubMed ID: 33141839
[TBL] [Abstract][Full Text] [Related]
5. Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis.
Lee SY; Lee CM; Ma B; Kamle S; Elias JA; Zhou Y; Lee CG
Front Pharmacol; 2022; 13():826471. PubMed ID: 35370755
[TBL] [Abstract][Full Text] [Related]
6. Multi-Modal Characterization of Monocytes in Idiopathic Pulmonary Fibrosis Reveals a Primed Type I Interferon Immune Phenotype.
Fraser E; Denney L; Antanaviciute A; Blirando K; Vuppusetty C; Zheng Y; Repapi E; Iotchkova V; Taylor S; Ashley N; St Noble V; Benamore R; Hoyles R; Clelland C; Rastrick JMD; Hardman CS; Alham NK; Rigby RE; Simmons A; Rehwinkel J; Ho LP
Front Immunol; 2021; 12():623430. PubMed ID: 33746960
[TBL] [Abstract][Full Text] [Related]
7. Chitinase 3-like-1 and its receptors in Hermansky-Pudlak syndrome-associated lung disease.
Zhou Y; He CH; Herzog EL; Peng X; Lee CM; Nguyen TH; Gulati M; Gochuico BR; Gahl WA; Slade ML; Lee CG; Elias JA
J Clin Invest; 2015 Aug; 125(8):3178-92. PubMed ID: 26121745
[TBL] [Abstract][Full Text] [Related]
8. Myeloid Fbxw7 Prevents Pulmonary Fibrosis by Suppressing TGF-β Production.
He J; Du Y; Li G; Xiao P; Sun X; Song W; Lai L; Xia M; Zhang J; Wang Q
Front Immunol; 2021; 12():760138. PubMed ID: 35069531
[TBL] [Abstract][Full Text] [Related]
9. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis.
Gibbons MA; MacKinnon AC; Ramachandran P; Dhaliwal K; Duffin R; Phythian-Adams AT; van Rooijen N; Haslett C; Howie SE; Simpson AJ; Hirani N; Gauldie J; Iredale JP; Sethi T; Forbes SJ
Am J Respir Crit Care Med; 2011 Sep; 184(5):569-81. PubMed ID: 21680953
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice.
Wang Y; Kuai Q; Gao F; Wang Y; He M; Zhou H; Han G; Jiang X; Ren S; Yu Q
Am J Respir Cell Mol Biol; 2019 Dec; 61(6):727-736. PubMed ID: 31162951
[TBL] [Abstract][Full Text] [Related]
11. Chitinase 3-like 1 deficiency ameliorates liver fibrosis by promoting hepatic macrophage apoptosis.
Higashiyama M; Tomita K; Sugihara N; Nakashima H; Furuhashi H; Nishikawa M; Inaba K; Wada A; Horiuchi K; Hanawa Y; Shibuya N; Kurihara C; Okada Y; Nishii S; Mizoguchi A; Hozumi H; Watanabe C; Komoto S; Yamamoto J; Seki S; Miura S; Hokari R
Hepatol Res; 2019 Nov; 49(11):1316-1328. PubMed ID: 31250532
[TBL] [Abstract][Full Text] [Related]
12. Breast Regression Protein-39/Chitinase 3-Like 1 Promotes Renal Fibrosis after Kidney Injury
Montgomery TA; Xu L; Mason S; Chinnadurai A; Lee CG; Elias JA; Cantley LG
J Am Soc Nephrol; 2017 Nov; 28(11):3218-3226. PubMed ID: 28679671
[TBL] [Abstract][Full Text] [Related]
13. Myeloid DNA methyltransferase3b deficiency aggravates pulmonary fibrosis by enhancing profibrotic macrophage activation.
Qin W; Spek CA; Scicluna BP; van der Poll T; Duitman J
Respir Res; 2022 Jun; 23(1):162. PubMed ID: 35725453
[TBL] [Abstract][Full Text] [Related]
14. SH2 Domain-Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis.
Tzouvelekis A; Yu G; Lino Cardenas CL; Herazo-Maya JD; Wang R; Woolard T; Zhang Y; Sakamoto K; Lee H; Yi JS; DeIuliis G; Xylourgidis N; Ahangari F; Lee PJ; Aidinis V; Herzog EL; Homer R; Bennett AM; Kaminski N
Am J Respir Crit Care Med; 2017 Feb; 195(4):500-514. PubMed ID: 27736153
[TBL] [Abstract][Full Text] [Related]
15. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.
Craig VJ; Zhang L; Hagood JS; Owen CA
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):585-600. PubMed ID: 26121236
[TBL] [Abstract][Full Text] [Related]
17. Role of Chitinase 3-Like-1 in Interleukin-18-Induced Pulmonary Type 1, Type 2, and Type 17 Inflammation; Alveolar Destruction; and Airway Fibrosis in the Murine Lung.
Kang MJ; Yoon CM; Nam M; Kim DH; Choi JM; Lee CG; Elias JA
Am J Respir Cell Mol Biol; 2015 Dec; 53(6):863-71. PubMed ID: 25955511
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF.
Ebener S; Barnowski S; Wotzkow C; Marti TM; Lopez-Rodriguez E; Crestani B; Blank F; Schmid RA; Geiser T; Funke M
Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L42-L55. PubMed ID: 27815256
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.
Wendisch D; Dietrich O; Mari T; von Stillfried S; Ibarra IL; Mittermaier M; Mache C; Chua RL; Knoll R; Timm S; Brumhard S; Krammer T; Zauber H; Hiller AL; Pascual-Reguant A; Mothes R; Bülow RD; Schulze J; Leipold AM; Djudjaj S; Erhard F; Geffers R; Pott F; Kazmierski J; Radke J; Pergantis P; Baßler K; Conrad C; Aschenbrenner AC; Sawitzki B; Landthaler M; Wyler E; Horst D; ; Hippenstiel S; Hocke A; Heppner FL; Uhrig A; Garcia C; Machleidt F; Herold S; Elezkurtaj S; Thibeault C; Witzenrath M; Cochain C; Suttorp N; Drosten C; Goffinet C; Kurth F; Schultze JL; Radbruch H; Ochs M; Eils R; Müller-Redetzky H; Hauser AE; Luecken MD; Theis FJ; Conrad C; Wolff T; Boor P; Selbach M; Saliba AE; Sander LE
Cell; 2021 Dec; 184(26):6243-6261.e27. PubMed ID: 34914922
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-specific deletion of activating transcription factor 6 alpha increases CD11b
Mekhael O; Revill SD; Hayat AI; Cass SP; MacDonald K; Vierhout M; Ayoub A; Reihani A; Padwal M; Imani J; Ayaub E; Yousof T; Dvorkin-Gheva A; Rullo A; Hirota JA; Richards CD; Bridgewater D; Stämpfli MR; Hambly N; Naqvi A; Kolb MR; Ask K
Immunol Cell Biol; 2023 May; 101(5):412-427. PubMed ID: 36862017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
